Copyright
©The Author(s) 2015.
World J Gastroenterol. Jul 21, 2015; 21(27): 8326-8339
Published online Jul 21, 2015. doi: 10.3748/wjg.v21.i27.8326
Published online Jul 21, 2015. doi: 10.3748/wjg.v21.i27.8326
Figure 1 Effects of givinostat in suppressing proliferation and migration of JS-1 cells.
A: Givinostat inhibits JS-1 cell proliferation in a concentration-dependent manner. The cell inhibition rate significantly differed between the group cotreated with givinostat ≥ 250 nmol/L plus lipopolysaccharide (LPS) and the group without LPS treatment (same givinostat concentration) (P < 0.05); B: The cell migration area significantly decreased in the group cotreated with givinostat plus LPS (P < 0.05); C: Compared with the control group, treatment with givinostat for 24 h or 48 h significantly suppressed expression of α-smooth muscle actin (SMA), transforming growth factor (TGF)-β1 and Vascular endothelial growth factor (VEGF). aP < 0.05, bP < 0.01 vs control group.
- Citation: Wang YG, Xu L, Wang T, Wei J, Meng WY, Wang N, Shi M. Givinostat inhibition of hepatic stellate cell proliferation and protein acetylation. World J Gastroenterol 2015; 21(27): 8326-8339
- URL: https://www.wjgnet.com/1007-9327/full/v21/i27/8326.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i27.8326